Menu

ARCA biopharma, Inc. ABIO

Full chart Compare
Set alert

Price alert · ABIO

All alert types
28.80 0.00 (+0.00%)

At closeAug 30, 2024, 4:00 PM EDT

2.25 Day range 28.80

52-week range unavailable

Revenue & Expenses

Other Income → Expenses: $6.59MExpenses → Selling, General & Admin: $20.76MExpenses → Research & Development: $42.65MExpenses → Other Operating Expenses: $2.34MGross Profit → Expenses: $46.86MRevenue → Gross Profit: $46.86MNet Loss → Expenses: $12.30MOther Income$6.59MGross Profit$46.86MNet Loss$12.30MExpenses$65.75MSelling, General & Admin$20.76MResearch & Development$42.65MOther Operating Expenses$2.34MRevenue$46.86M

Latest period ending Dec 31, 2023 · select a line to chart its full history

ABIO annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-7.30M-10.60M-19.34M-9.77M-5.81M
-5.34M-9.93M-19.32M-9.74M-5.48M
-0.37-0.69-1.39-2.07-4.15
ABIO annual balance sheet
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
37.43M42.45M53.36M49.07M8.36M
37.86M43.09M54.92M50.43M8.54M
841.00K1.41M3.88M3.91M926.00K
204.00K280.00K383.00K409.00K0
37.02M41.67M51.04M46.52M7.61M
ABIO annual cash flow
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-5.01M-10.91M-18.76M-7.72M-4.80M
-5.01M-10.91M4.29M40.71M1.75M